Omega Fund Management

Omega Fund Management as of June 30, 2022

Portfolio Holdings for Omega Fund Management

Omega Fund Management holds 21 positions in its portfolio as reported in the June 2022 quarterly 13F filing

Company (Ticker) Portfolio Weight Valued At Change in Shares Share Count Share Price
Replimune Group Common Stock (REPL) 26.1 $82M 4.7M 17.48
Nuvation Bio Common Stock Class A (NUVB) 15.8 $49M 15M 3.24
Imago Biosciences Common Stock 12.9 $40M 3.0M 13.39
Morphic Holding Common Stock (MORF) 7.0 $22M 1.0M 21.70
Cincor Pharma Common Stock 5.8 $18M 966k 18.84
Alpine Immune Sciences Common Stock 5.5 $17M 2.0M 8.51
Kronos Bio Common Stock 4.4 $14M 3.8M 3.64
Arcutis Biothereapeutics Common Stock (ARQT) 4.2 $13M 624k 21.31
Gossamer Bio Common Stock (GOSS) 4.0 $13M 1.5M 8.37
Ikena Oncology Common Stock (IKNA) 3.2 $10M 2.2M 4.43
Immunic Common Stock 2.0 $6.2M 1.8M 3.47
Sana Biotechnology Common Stock (SANA) 1.7 $5.4M 844k 6.43
Omega Alpha SPAC Common Stock Class A 1.6 $4.9M 501k 9.85
Theseus Pharmaceuticals Common Stock 1.3 $3.9M 712k 5.53
Paratek Pharmaceuticals Common Stock 1.2 $3.8M 2.0M 1.93
Spruce Biosciences Common Stock 1.2 $3.8M 2.2M 1.74
Syros Pharmaceuticals Common Stock 0.8 $2.4M 2.5M 0.96
Immunocore Holdings Ads (IMCR) 0.6 $1.9M 52k 37.31
ESSA Pharma Common Stock (EPIX) 0.3 $1.0M 328k 3.15
Jounce Therapeutics Common Stock 0.3 $835k 276k 3.03
Senti Biosciences Common Stock 0.1 $386k 196k 1.97